Testing Different COVID-19 Vaccination Strategies Using an Agent-Based Modeling Approach

Vaccination has been the long-awaited solution ever since the COVID-19 pandemic started. But the problem is that vaccine shots cannot be delivered at the same time to all populations, because of their limited quantity from one side, and their high demand from the other side. Therefore, countries nee...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:SN computer science 2022-07, Vol.3 (4), p.307-307, Article 307
Hauptverfasser: Trad, Fouad, El Falou, Salah
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Vaccination has been the long-awaited solution ever since the COVID-19 pandemic started. But the problem is that vaccine shots cannot be delivered at the same time to all populations, because of their limited quantity from one side, and their high demand from the other side. Therefore, countries need a way to test the effect of different distribution strategies before applying them. But how can they do this? To assist countries with this task, we built an agent-based model that runs on top of the Monte Carlo algorithm. This model simulates the spread of COVID-19 in a country where we can apply different NPIs at different times, and we can supply different kinds of vaccines using different strategies. In this study, we tested the outcomes of four vaccination strategies: older first, younger first, a mixed strategy, and a random strategy. We simulated these strategies in two different countries: France and Colombia. Then, we performed a comparative analysis to find which strategy might be the best for each country. Our results show that what is good for a country is not necessarily the best for the other one. Therefore, we proved that a vaccination strategy should be adapted to the structure of the population we are vaccinating. The system we built helps countries in this direction by allowing them to test the outcomes of their strategies before applying them in real life to select the one that minimizes human losses (deaths and infections).
ISSN:2661-8907
2662-995X
2661-8907
DOI:10.1007/s42979-022-01199-6